Insider · CIK 0001210529

OCLASSEN GLENN A

Reports to the SEC for 4 companies · POINT RICHMOND, CA

sec.gov

Transactions

Companies

Filings

CIK

0001210529

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-06-12	VRCAVerrica Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,834 sh	—	—	5,834
2019-01-28	VRCAVerrica Pharmaceuticals Inc.G Gift	Director	GGift	−75K sh	—	—	65,421
2019-01-25	VRCAVerrica Pharmaceuticals Inc.G Gift	Director	GGift	−150K sh	—	—	140,421
2018-06-19	VRCAVerrica Pharmaceuticals Inc.C Conversion	Director	CConversion	+201K sh	—	—	290,421
2018-06-19	VRCAVerrica Pharmaceuticals Inc. · Series A Convertible Preferred StockC Conversion	Director	CConversion	−201K sh	—	—	0
2018-06-14	VRCAVerrica Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17.5K sh	—	—	17,502
2014-10-30	Paratek Pharmaceuticals, Inc.A Award	Director, President and CEO	AAward	+10.6K sh	$21.59	+$229K	36,513
2014-10-30	Paratek Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−8,655 sh	—	—	0
2014-10-30	Paratek Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−7,500 sh	—	—	0
2014-10-30	Paratek Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−14.2K sh	—	—	0
2014-10-30	Paratek Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−12.7K sh	—	—	0
2014-10-30	Paratek Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−12.9K sh	—	—	0
2014-10-30	Paratek Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−15K sh	—	—	0
2014-10-30	Paratek Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−20.8K sh	—	—	0
2014-10-30	Paratek Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−18.8K sh	—	—	0
2013-07-15	Paratek Pharmaceuticals, Inc.Common Stock Option (right to buy)A Award	Director, President and CEO	AAward	+225K sh	—	—	225,000
2013-01-07	Paratek Pharmaceuticals, Inc.Common Stock Option (right to buy)A Award	Director, President and CEO	AAward	+250K sh	—	—	250,000
2012-02-01	Paratek Pharmaceuticals, Inc.Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+180K sh	—	—	180,000
2011-09-19	Paratek Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+10K sh	$5.80	+$58K	310,800
2011-09-19	Paratek Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+10K sh	$5.80	+$58K	73,457
2011-08-24	Paratek Pharmaceuticals, Inc.Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+155K sh	—	—	155,000
2011-08-11	Paratek Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+2,167 sh	$2.82	+$6,110.94	300,800
2011-08-10	Paratek Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+27.8K sh	$2.82	+$78.5K	298,633
2011-02-02	Paratek Pharmaceuticals, Inc.Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+152K sh	—	—	152,000
2010-01-14	Paratek Pharmaceuticals, Inc.Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+112K sh	—	—	111,800
2010-01-14	Paratek Pharmaceuticals, Inc.Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+59K sh	—	—	59,000
2009-08-25	Paratek Pharmaceuticals, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+149K sh	$0.88	+$132K	184,710
2009-08-25	Paratek Pharmaceuticals, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+76.7K sh	$1.77	+$136K	261,442
2009-08-25	Paratek Pharmaceuticals, Inc.Options to Purchase Common StockM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−149K sh	—	—	9,957
2009-08-25	Paratek Pharmaceuticals, Inc.Options to Purchase Common StockM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−76.7K sh	—	—	87,397
2009-08-25	Paratek Pharmaceuticals, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+149K sh	$0.88	+$132K	186,710
2009-08-25	Paratek Pharmaceuticals, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+76.7K sh	$1.77	+$136K	263,442
2009-08-21	Paratek Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+8,700 sh	$9.50	+$82.7K	35,347
2009-02-12	Paratek Pharmaceuticals, Inc.Employee stock option (right to buy)A Award	Director, President and CEO	AAward	+90K sh	—	—	90,000
2009-01-30	Paratek Pharmaceuticals, Inc.A Award	Director, President and CEO	AAward	+26.6K sh	—	—	28,647
2009-01-30	Paratek Pharmaceuticals, Inc.A Award	Director, President and CEO	AAward	+57.5K sh	—	—	63,457
2009-01-30	Paratek Pharmaceuticals, Inc.Employee stock option (right to buy)A Award	Director, President and CEO	AAward	+159K sh	—	—	159,320
2009-01-30	Paratek Pharmaceuticals, Inc.Employee stock option (right to buy)A Award	Director, President and CEO	AAward	+164K sh	—	—	164,129
2009-01-30	Paratek Pharmaceuticals, Inc.Common Stock WarrantA Award	Director, President and CEO	AAward	+1,098 sh	—	—	1,098
2003-11-03	CONNETICS CORPM Exercise/Conversion	Former Director	MExercise/Conversion	+2,000 sh	$4.75	+$9,500	32,421
2003-11-03	CONNETICS CORPS Sale	Former Director	SSale	−2,000 sh	$17.78	−$35.6K	30,421
2003-11-03	CONNETICS CORPNon-Qualified Stock Option (right to buy)M Exercise/Conversion	Former Director	MExercise/Conversion	−2,000 sh	$17.78	−$35.6K	137,000
2003-10-01	CONNETICS CORPM Exercise/Conversion	Former Director	MExercise/Conversion	+2,000 sh	$4.75	+$9,500	32,421
2003-10-01	CONNETICS CORPS Sale	Former Director	SSale	−2,000 sh	$17.69	−$35.4K	30,421
2003-10-01	CONNETICS CORPNon-Qualified Stock Option (right to buy)M Exercise/Conversion	Former Director	MExercise/Conversion	−2,000 sh	$17.69	−$35.4K	139,000
2003-09-02	CONNETICS CORPM Exercise/Conversion	Former Director	MExercise/Conversion	+2,000 sh	$4.75	+$9,500	45,171
2003-09-02	CONNETICS CORPS Sale	Former Director	SSale	−2,000 sh	$18.69	−$37.4K	43,171
2003-09-02	CONNETICS CORPNon-Qualified Stock Option (right to buy)M Exercise/Conversion	Former Director	MExercise/Conversion	−2,000 sh	$18.69	−$37.4K	141,000
2003-08-01	CONNETICS CORPM Exercise/Conversion	Former Director	MExercise/Conversion	+2,000 sh	$4.75	+$9,500	45,171
2003-08-01	CONNETICS CORPS Sale	Former Director	SSale	−2,000 sh	$17.86	−$35.7K	43,171

Recent filings

Accepted (ET)
Jun 144
OCLASSEN GLENN A0001209191-19-037169
SEC(opens sec.gov)
Jan 314
OCLASSEN GLENN A0001209191-19-006198
SEC(opens sec.gov)
Jun 194
OCLASSEN GLENN A0001209191-18-038596
SEC(opens sec.gov)
Jun 184
OCLASSEN GLENN A0001209191-18-038308
SEC(opens sec.gov)
Oct 304
Transcept Pharmaceuticals Inc0001181431-14-035067
SEC(opens sec.gov)
Jul 184
Transcept Pharmaceuticals Inc0001181431-13-040636
SEC(opens sec.gov)
Jan 84
OCLASSEN GLENN A0001181431-13-002495
SEC(opens sec.gov)
Feb 24
OCLASSEN GLENN A0001181431-12-005295
SEC(opens sec.gov)
Sep 204
OCLASSEN GLENN A0001181431-11-050006
SEC(opens sec.gov)

Companies

Address

C/O TRANSCEPT PHARMACEUTICALS, INC. 1003 W. CUTTING BLVD., SUITE #110

POINT RICHMOND, CA, 94804